Clinical evidence for EBC-1013 wound healing pharmaceutical

April, 2018 Update

Early results from three current veterinary trials examining the ability of EBC-1013 to address burns, acute and chronic wounds are very promising. These initial clinical results are corroborating the unique mode of action we have been seeing in the laboratory. We look forward to providing updates to this programme as more data is obtained.